Jeffrey L Probstfield

1941 -

Country of citizenship: United States of America

Occupation: researcher, internist

Bibliographic databases:

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 162

Date

Title

Authors

1982-12-01

Occupational screenings: recruitment from private industry

Jeffrey L Probstfield
1984-08-01

Coronary risk factors and exercise test performance in asymptomatic hypercholesterolemic men: application of proportional hazards analysis

Jeffrey L Probstfield
1986-12-01

High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial

Jeffrey L Probstfield
1986-08-01

Predictive value of the exercise tolerance test for mortality in North American men: the Lipid Research Clinics Mortality Follow-up Study

Jeffrey L Probstfield
1986-01-01

Detection of dyslipoproteinemia with the use of plasma total cholesterol and triglyceride as screening tests. The Lipid Research Clinics Program Prevalence Study

Jeffrey L Probstfield
1987-04-01

Smoking, physical activity, and other predictors of endurance and heart rate response to exercise in asymptomatic hypercholesterolemic men. The Lipid Research Clinics Coronary Primary Prevention Trial

Jeffrey L Probstfield
1989-04-01

Surrogate endpoints in clinical trials: cardiovascular diseases.

Jeffrey L Probstfield
1989-01-01

The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group

Nemat O. Borhani, J. David Curb, Jeffrey L Probstfield
1989-10-01

The systolic hypertension in the elderly program. Implications for nursing practice and research

Eleanor B Schron, Jeffrey L Probstfield
1989-09-01

Coronary heart disease morbidity and mortality in hypercholesterolemic men predicted from an exercise test: the Lipid Research Clinics Coronary Primary Prevention Trial

Jeffrey L Probstfield
1989-01-01

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

Jeffrey L Probstfield
1990-07-01

Evaluating effects of treatment in subgroups of patients within a clinical trial: the case of non-Q-wave myocardial infarction and beta blockers

Jeffrey L Probstfield
1990-01-01

Systolic hypertension in the elderly: controlled or uncontrolled

Jeffrey L Probstfield
1991-03-01

Systolic Hypertension in the Elderly Program (SHEP). Part 1: Rationale and design

Nemat O. Borhani, Jeffrey L Probstfield
1991-07-01

Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials

Jeffrey L Probstfield
1991-03-01

Progression and regression of carotid atherosclerosis in clinical trials

Jeffrey L Probstfield
1992-07-01

Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia

Jeffrey L Probstfield
1992-10-01

Recruitment strategies in the studies of left ventricular dysfunction (SOLVD): strategies for screening and enrollment in two concurrent but separate trials. The SOLVD Investigators

Jeffrey L Probstfield
1993-11-01

Conclusions and implications of the systolic hypertension in the elderly program

Jeffrey L Probstfield
1993-10-01

Statistical considerations in monitoring the Systolic Hypertension in the Elderly Program (SHEP).

Jeffrey L Probstfield
1993-03-01

Methodological issues facing studies of atherosclerotic change

Jeffrey L Probstfield
1994-08-01

Tolerability of enalapril initiation by patients with left ventricular dysfunction: results of the medication challenge phase of the Studies of Left Ventricular Dysfunction.

Jeffrey L Probstfield
1994-10-01

Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group

Jeffrey L Probstfield
1995-09-01

Results of the primary outcome measure and clinical events from the Asymptomatic Carotid Artery Progression Study

Jeffrey L Probstfield
1995-02-01

Neurohumoral variability in left ventricular dysfunction. SOLVD Investigators. Studies of Left Ventricular Dysfunction

Chang-seng Liang, Jeffrey L Probstfield
1995-12-01

Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP).

Jeffrey L Probstfield
1996-02-01

Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators

Jeffrey L Probstfield
1996-08-01

Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators

Jeffrey L Probstfield
1997-12-01

Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study

Jeffrey L Probstfield, Salim Yusuf, Aldo P. Maggioni
1998-04-01

Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperat

Eleanor B Schron, J. David Curb, Jeffrey L Probstfield
1998-03-01

Smoking, high SBP and cholesterol levels were associated with increased risk of carotid artery stenosis

Jeffrey L Probstfield
1998-12-01

Garlic tablets are ineffective in hypercholesterolemia

Jeffrey L Probstfield

Comments

There is nothing here

Lists

There is nothing here

Human -

Welcome to inventaire

The library of your friends and communities

Learn more

Author

Jeffrey L Probstfield

Series

Works

Articles 162

Comments

Lists

Fediverse followers 0

Welcome to inventaire